Filing Details
- Accession Number:
- 0001209191-15-081354
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-19 17:51:48
- Reporting Period:
- 2015-11-17
- Filing Date:
- 2015-11-19
- Accepted Time:
- 2015-11-19 17:51:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236927 | A Paul Friedman | 1801 Augustine Cut-Off Wilmington DE 19803 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-17 | 100,000 | $17.79 | 397,518 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-17 | 7,052 | $112.71 | 390,466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-17 | 42,948 | $112.53 | 347,518 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-17 | 50,000 | $111.37 | 297,518 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-18 | 125,000 | $17.79 | 422,518 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-18 | 86,132 | $115.42 | 336,386 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-11-18 | 38,868 | $115.12 | 297,518 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-11-17 | 5,621 | $0.00 | 5,621 | $17.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-11-17 | 94,379 | $0.00 | 94,379 | $17.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-11-18 | 125,000 | $0.00 | 125,000 | $17.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-01-18 | No | 4 | M | Direct | |
| 125,000 | 2019-01-18 | No | 4 | M | Direct | |
| 0 | 2019-01-18 | No | 4 | M | Direct |
Footnotes
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $112.52 - $112.82.
- Represents weighted average sale price. Actual sale prices ranged from $112.00 - $113.41.
- Represents weighted average sale price. Actual sale prices ranged from $110.04 - $112.49.
- Represents weighted average sale price. Actual sale prices ranged from $115.00 - $116.35.
- Represents weighted average sale price. Actual sale prices ranged from $115.00 - $115.89.
- Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Billionaire Hedge Funds
